+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Newborn Screening Market by Technology (High Performance Liquid Chromatography, Immunoassay, Molecular Techniques), Test Type (Cystic Fibrosis, Endocrine Disorders, Hemoglobin Disorders), End User, Sample Type - Global Forecast 2025-2030- Product Image
Newborn Screening Market by Technology (High Performance Liquid Chromatography, Immunoassay, Molecular Techniques), Test Type (Cystic Fibrosis, Endocrine Disorders, Hemoglobin Disorders), End User, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Newborn Screening Market by Technology (High Performance Liquid Chromatography, Immunoassay, Molecular Techniques), Test Type (Cystic Fibrosis, Endocrine Disorders, Hemoglobin Disorders), End User, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674209
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The newborn screening market is undergoing a fundamental transformation, shaped by rapid technological innovation and evolving healthcare policy. Senior decision-makers face a dynamic landscape, requiring data-driven choices to optimize value, navigate regulatory shifts, and expand diagnostic reach within pediatric care.

Market Snapshot: Newborn Screening Market Growth & Outlook

The newborn screening market grew from USD 1.06 billion in 2024 to USD 1.16 billion in 2025. It is projected to maintain a compound annual growth rate (CAGR) of 8.83%, reaching USD 1.76 billion by 2030. Upward trends are propelled by advances in high-throughput screening technologies, increased adoption of expanded testing panels, and heightened government focus on early disease detection programs.

Scope & Segmentation: Comprehensive Coverage Across Technologies, Test Types, and Regions

  • Technology Platforms: High-performance liquid chromatography, immunoassays, molecular techniques (PCR, Sanger sequencing), next-generation sequencing, tandem mass spectrometry
  • Test Categories: Cystic fibrosis, endocrine disorders, hemoglobinopathies, inborn errors of metabolism
  • End User Environments: Diagnostic laboratories, hospitals and clinics, research laboratories
  • Sample Types: Dried blood spot, serum sample
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and several key Southeast Asian markets)
  • Company Coverage: PerkinElmer, Thermo Fisher Scientific, Danaher, Agilent Technologies, Waters Corporation, Abbott Laboratories, Bio-Rad Laboratories, BioMérieux, Siemens Healthineers, Shimadzu Corporation

Key Takeaways for Senior Decision-Makers

  • The newborn screening market is evolving beyond limited panels, now encompassing broad genomic and metabolic testing supported by improved assay sensitivity and throughput.
  • Multiomic strategies, integrating both biochemical and genomic assays, are increasingly adopted to provide more robust, tailored diagnostics for neonates.
  • High-throughput platforms such as tandem mass spectrometry and next-generation sequencing drive operational efficiencies, enabling the identification of rare disorders at scale.
  • Reliable dried blood spot testing remains the industry standard; however, adoption of serum-based assays grows to extend biomarker detection capabilities and complement existing protocols.
  • Strategic alliances among life science companies, biotech innovators, and healthcare providers are key to advancing workflow automation and data integration—improving both result accuracy and turnaround time.
  • Regional differences in policy, healthcare infrastructure, and funding generate unique opportunities and challenges for market entry and expansion strategy.

Tariff Impact: Navigating Trade Policy Changes and Supply Chain Strategies

Recent United States tariff implementations have increased import duties on essential newborn screening consumables, including reagents and precision instruments produced abroad. As a result, diagnostic laboratories have reassessed procurement models by diversifying suppliers, exploring near-shore manufacturing partnerships, and negotiating tariff exemptions for critical public health products. Investments in laboratory workflow automation and lean process improvements are being deployed to offset increased operating costs and mitigate supply disruption risks.

Methodology & Data Sources

This report integrates primary insights from expert interviews with clinicians, laboratory directors, and industry leaders, complemented by comprehensive secondary research from peer-reviewed sources, regulatory filings, and clinical guidelines. Triangulation and validation workshops with subject-matter experts reinforce the integrity and actionable nature of findings.

Why This Report Matters for B2B Decision-Makers

  • Informs strategic investment by providing a complete landscape review of technology adoption, regulatory trends, and operational models in newborn screening.
  • Uncovers actionable segmentation intelligence for targeted market entry, expansion, or partnership development.
  • Supports risk management and long-term sustainability planning by analyzing both growth drivers and challenges such as evolving tariffs or supply chain considerations.

Conclusion

The newborn screening market is positioned at a critical point of innovation and operational change. Stakeholders who effectively align technology adoption, partnerships, and procurement strategy will drive improved clinical outcomes and sustain competitiveness in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of next-generation sequencing panels to detect rare genetic disorders in newborns
5.2. Integration of digital health platforms for real time data sharing and follow up in newborn screening
5.3. Public private partnerships driving nationwide expansions of newborn screening infrastructure in underserved regions
5.4. Adoption of point of care testing solutions to accelerate metabolic disorder detection in rural clinics
5.5. Harmonization of policies and reimbursement frameworks to support uniform newborn screening across states
5.6. Emerging metabolomic biomarkers enabling broader multiplex newborn screening for inborn errors of metabolism
5.7. Utilization of artificial intelligence algorithms for interpreting complex genomic variants in neonatal screening
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Newborn Screening Market, by Technology
8.1. Introduction
8.2. High Performance Liquid Chromatography
8.3. Immunoassay
8.4. Molecular Techniques
8.4.1. Polymerase Chain Reaction
8.4.2. Sanger Sequencing
8.5. Next Generation Sequencing
8.6. Tandem Mass Spectrometry
9. Newborn Screening Market, by Test Type
9.1. Introduction
9.2. Cystic Fibrosis
9.3. Endocrine Disorders
9.4. Hemoglobin Disorders
9.5. Inborn Errors Of Metabolism
10. Newborn Screening Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals And Clinics
10.4. Research Laboratories
11. Newborn Screening Market, by Sample Type
11.1. Introduction
11.2. Dried Blood Spot
11.3. Serum Sample
12. Americas Newborn Screening Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Newborn Screening Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Newborn Screening Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. PerkinElmer, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Danaher Corporation
15.3.4. Agilent Technologies, Inc.
15.3.5. Waters Corporation
15.3.6. Abbott Laboratories
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. BioMérieux SA
15.3.9. Siemens Healthineers AG
15.3.10. Shimadzu Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEWBORN SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NEWBORN SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NEWBORN SCREENING MARKET: RESEARCHAI
FIGURE 24. NEWBORN SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 25. NEWBORN SCREENING MARKET: RESEARCHCONTACTS
FIGURE 26. NEWBORN SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEWBORN SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEWBORN SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEWBORN SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEWBORN SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEWBORN SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEWBORN SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEWBORN SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEWBORN SCREENING MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEWBORN SCREENING MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEWBORN SCREENING MARKET SIZE, BY ENDOCRINE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEWBORN SCREENING MARKET SIZE, BY ENDOCRINE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HEMOGLOBIN DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HEMOGLOBIN DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEWBORN SCREENING MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEWBORN SCREENING MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEWBORN SCREENING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEWBORN SCREENING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SERUM SAMPLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SERUM SAMPLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 76. CANADA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 77. CANADA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 78. CANADA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 79. CANADA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. CANADA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. CANADA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 84. CANADA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. MEXICO NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. MEXICO NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 88. MEXICO NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 89. MEXICO NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. MEXICO NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. MEXICO NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 94. MEXICO NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 137. GERMANY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. GERMANY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. GERMANY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 140. GERMANY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 141. GERMANY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 142. GERMANY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 143. GERMANY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. GERMANY NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. GERMANY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 146. GERMANY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 147. FRANCE NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. FRANCE NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. FRANCE NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 150. FRANCE NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 151. FRANCE NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. FRANCE NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. FRANCE NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. FRANCE NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. FRANCE NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. FRANCE NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 167. ITALY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. ITALY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. ITALY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 170. ITALY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 171. ITALY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. ITALY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. ITALY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ITALY NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ITALY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. ITALY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. SPAIN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. SPAIN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. SPAIN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 180. SPAIN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 181. SPAIN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 182. SPAIN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 183. SPAIN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. SPAIN NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. SPAIN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 186. SPAIN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. DENMARK NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. DENMARK NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. DENMARK NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 220. DENMARK NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 221. DENMARK NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 222. DENMARK NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 223. DENMARK NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. DENMARK NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. DENMARK NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 226. DENMARK NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 237. QATAR NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. QATAR NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. QATAR NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 240. QATAR NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 241. QATAR NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 242. QATAR NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 243. QATAR NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. QATAR NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. QATAR NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. QATAR NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. FINLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. FINLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. FINLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 250. FINLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 251. FINLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 252. FINLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 253. FINLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. FINLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FINLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 256. FINLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 277. EGYPT NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. EGYPT NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. EGYPT NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 280. EGYPT NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 281. EGYPT NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 282. EGYPT NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 283. EGYPT NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. EGYPT NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. EGYPT NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 286. EGYPT NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 287. TURKEY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. TURKEY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. TURKEY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 290. TURKEY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 291. TURKEY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 292. TURKEY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 293. TURKEY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. TURKEY NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. TURKEY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 296. TURKEY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 307. NORWAY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. NORWAY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. NORWAY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 310. NORWAY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 311. NORWAY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 312. NORWAY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 313. NORWAY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NORWAY NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. NORWAY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 316. NORWAY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 317. POLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. POLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. POLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 320. POLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 321. POLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 322. POLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 323. POLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. POLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. POLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 326. POLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 333. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 336. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 346. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 347. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 348. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 349. CHINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 350. CHINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 351. CHINA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2024 (USD MILLION)
TABLE 352. CH

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Newborn Screening market report include:
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Waters Corporation
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • BioMérieux SA
  • Siemens Healthineers AG
  • Shimadzu Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.76 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032 - Product Image

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Newborn Screening - Global Strategic Business Report - Product Image

Newborn Screening - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Newborn Screening Market: Analysis By Product, By Technology, By Test Type, By End User, By Region Size and Trends and Forecast up to 2029 - Product Image

Newborn Screening Market: Analysis By Product, By Technology, By Test Type, By End User, By Region Size and Trends and Forecast up to 2029

  • Report
  • 152 Pages
  • Global
From
Newborn Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Newborn Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Prenatal Testing & Newborn Screening Market Report 2025 - Product Image

Prenatal Testing & Newborn Screening Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.